Aparicio, Carlos http://orcid.org/0000-0002-2069-691X
Polido, Waldemar D.
Chow, James
Davó, Rubén
Al-Nawas, Bilal
Article History
Received: 20 December 2021
Accepted: 9 March 2022
First Online: 1 April 2022
Declarations
:
: This is a prospective non-interventional study. Study subjects were consecutive patients who presented with indications for zygomatic implants. All participants signed a consent form to undergo regular zygomatic surgery and prosthetic rehabilitation. Indiana University HRPP staff determined (Protocol#:12562) the present study is not human subject research and does not require further IRB review. All procedures involving human participants were in accordance with the ethical standards of the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: All data published here are under the consent for publication.
: Carlos Aparicio is the founder president of Zygoma ZAGA Centers and occasionally provides CE activities for Straumann Group and Versah Osseodensification Company. Waldemar Polido occasionally provides CE activities for Straumann Group and Geistlich Biomaterials. James Chow and Rubén Davó occasionally provide CE activities for the Straumann Group. Bilal Al-Nawas occasionally provide CE activities and get research grants for Straumann Group, BEGO, Camlog, Dentsply, and Geistlich Biomaterials.